Kosacz Barbara 4
4 · Athira Pharma, Inc. · Filed Mar 8, 2021
Insider Transaction Report
Form 4
Kosacz Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-03-04+27,742→ 27,742 totalExercise: $19.29Exp: 2031-03-03→ Common Stock (27,742 underlying)
Footnotes (1)
- [F1]One thirty-sixth of the shares subject to the option will vest on April 4, 2021 and one thirty-sixth of the shares subject to the option will vest each month thereafter.